Azilsartan Medoxomil Tablet
Product Images NDC 52536-008

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Azilsartan Medoxomil (NDC 52536-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wilshire Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

40mg-label (Azilsartan Medoxomil 40mg Label Rev00)

This text contains information about Azilsartan Medoxomil tablets, with each white tablet containing 42.68 mg of azilsartan kamedoxomil (equivalent to 40 mg of azilsartan medoxomil). The package includes 30 tablets and should not be repackaged or have desiccant canisters removed. It should be stored at 25°C (77°F) with excursions permitted to 15-30°C (59-86°F) and protected from moisture and light. The usual dosage information is available in the package insert. The tablets are for prescription use only.*

FDA Label Image

80mg-label (Azilsartan Medoxomil 80mg Label Rev00)

This text provides information about Azilsartan Medoxomil tablets, including dosage instructions and storage recommendations. The tablets should not be repackaged or removed from the original container. Each white tablet contains 85.36 mg of azilsartan kamedoxomil (equivalent to 80 mg of azilsartan medoxomil). The recommended storage temperature is 25°C (77°F) with excursions permitted between 15-30°C (59-86°F). It is important to keep the container tightly closed, protect the tablets from moisture and light, and refer to the package insert for usual dosage instructions. This medication is for prescription use only.*

FDA Label Image

Figu-1 (Figure 01)

This is a population description table that includes information on age groups, gender, race, renal impairment levels, hepatic impairment levels, and pediatric doses for a certain medication. It provides recommendations for dose adjustments based on different criteria such as age, gender, and impairment levels. The table also mentions the lack of experience in certain scenarios.*

FDA Label Image

Figu-2 (Figure 2)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.